查看购物车
  • Traditional Chinese
  • English
  • Japanese
全球 EPA 和 DHA 市场 - 2023-2030 年
市场调查报告书
商品编码
1316258

全球 EPA 和 DHA 市场 - 2023-2030 年

Global EPA & DHA Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概述

全球 EPA 和 DHA 市场规模在 2022 年达到 18 亿美元，预计到 2030 年将达到 29 亿美元，并在 2023-2030 年期间以 6.5% 的复合年增长率增长。EPA 和 DHA 市场正在见证产品多样化和创新的上升趋势。例如，一些公司正在推出基于藻类的 EPA 和 DHA 补充剂，以满足人们对可持续的植物性欧米伽-3 来源日益增长的需求。

由于人们越来越意识到欧米伽-3 脂肪酸对健康的益处，EPA 和 DHA 市场正呈现大幅增长。EPA（二十碳五烯酸）和 DHA（二十二碳六烯酸）是支持心血管和大脑健康的重要成分。市场提供多种产品选择，包括鱼油、藻油和欧米伽-3 补充剂，方便消费者在饮食中摄入这些营养素。

富含欧米伽-3 的功能性食品的采用率不断上升，推动了 EPA 和 DHA 市场的发展。食品制造商正在将 EPA 和 DHA 添加到各种强化食品和饮料中，以迎合注重健康的消费者的需求。例如，富含欧米伽-3 的牛奶、酸奶和谷类食品的供应量不断增加。此外，人们对宠物健康和营养的日益关注也促使 EPA 和 DHA 被添加到宠物食品中，推动了宠物营养品市场的扩大。

市场动态

全球对 Omega-3 益处和保健建议的重视推动了 EPA 和 DHA 市场的增长

全球卫生组织和监管机构一直在强调欧米伽-3 脂肪酸对促进公众健康的重要性。各国政府正在实施相关政策，通过膳食指南和公共卫生运动鼓励人们食用 EPA 和 DHA。此外，还制定了相关法规来确保 EPA 和 DHA 产品的质量和安全，从而为消费者提供标准化和可靠的补充剂。

这些支持措施增强了消费者的信心，从而推动了 EPA 和 DHA 的市场趋势。此外，omega-3 补充剂被纳入医疗保健建议和治疗方案也促进了市场增长。医疗保健专业人员越来越多地向有心血管问题、炎症和其他健康问题的患者推荐 EPA 和 DHA 补充剂，从而进一步推动了对这些必需脂肪酸的需求。

对植物来源的需求增加推动了 EPA 和 DHA 市场的增长

随着人们对可持续发展和环境问题的认识不断提高，对藻油等植物性 EPA 和 DHA 来源的需求也在不断增长。藻类提取的欧米伽-3 补充剂在寻求鱼油替代品的素食主义者和素食消费者中越来越受欢迎。藻油提供了一种可持续的环保选择，减少了对海洋资源的压力，减轻了捕鱼对环境的影响。

随着以植物为基础的运动逐渐兴起，对来自藻类的 EPA 和 DHA 补充剂的需求预计将上升，从而推动 EPA 和 DHA 市场的增长。预计藻类 EPA 和 DHA 产品的市场份额将随着消费者偏好的变化和道德因素的考虑而增加。

污染物问题给 EPA 和 DHA 市场增长带来挑战

EPA 和 DHA 市场的主要制约因素之一是鱼油和海产品中污染物的潜在风险。由于这些欧米加-3 脂肪酸通常来自鱼类和其他海洋生物，因此环境污染物、重金属和毒素有可能在它们体内积累。汞、多氯联苯和二恶英等污染物可能存在于某些鱼类物种和海洋油中，从而引发消费者对产品安全和潜在健康风险的担忧。

为解决这一制约因素，EPA 和 DHA 市场的制造商和供应商需要实施严格的质量控制措施，如第三方检测和认证，以确保其产品符合安全标准和法规要求。提供纯化和高质量的 EPA 和 DHA 补充剂有助于建立消费者信任，克服市场上的这一制约因素。

COVID-19 影响分析

COVID-19 分析包括 COVID 前情景、COVID 情景和 COVID 后情景，以及定价动态（包括大流行期间和之后的定价变化，并与 COVID 前情景进行比较）、供求光谱（由于贸易限制、封锁和后续问题而导致的供求变化）、政府倡议（政府机构为振兴市场、部门或行业而采取的倡议）和制造商战略倡议（此处将涵盖制造商为缓解 COVID 问题而采取的措施）。

目 录

第 1 章：研究方法与范围

  • 研究方法
  • 报告的研究目标和范围

第2章：市场定义与概述

第3章：执行摘要

  • 按类型分類的市场摘要
  • 按来源分類的市场摘要
  • 按应用分類的市场片段
  • 按地区分類的市场摘要

第 4 章：市场动态

  • 市场影响因素
    • 驱动因素
    • 限制因素
    • 机会
    • 影响分析

第 5 章：行业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章：COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的情况
    • COVID-19 期间的情景
    • COVID-19 之后的情况
  • COVID-19 期间的定价动态
  • 供求关系
  • 大流行期间与市场相关的政府倡议
  • 制造商的战略倡议
  • 结论

第 7 章：按类型划分

  • 二十碳五烯酸 (EPA)
  • 二十二碳六烯酸 (DHA)

第 8 章：按来源

  • 藻油
  • 磷虾油
  • 鱼油
  • 其他

第 9 章：按应用分类

  • 婴儿配方奶粉
  • 膳食补充剂
  • 强化食品和饮料
  • 药品
  • 其他

第 10 章：按地区划分

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第 11 章 ：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 合併与收购分析

第十二章 ：公司简介

  • BASF SE
    • 公司概况
    • 产品组合和说明
    • 财务概况
    • 主要发展
  • Koninklijke DSM NV
  • Corbion N.V.
  • The Archer Daniels Midland Company
  • Croda International Plc
  • KD Pharma Group
  • Lonza Group Ltd.
  • Omega Protein Corporation
  • GC Rieber Oils AS
  • Polaris

第 13 章 ：附录

简介目录
Product Code: FB6504

Market Overview

The Global EPA & DHA Market reached US$ 1.8 billion in 2022 and is expected to reach US$ 2.9 billion by 2030 and is expected to grow with a CAGR of 6.5% during the forecast period 2023-2030. The EPA and DHA market is witnessing a rising trend in product diversification and innovation. For instance, companies are introducing algae-based EPA and DHA supplements to cater to the growing demand for sustainable and plant-based sources of omega-3s.

The EPA and DHA market is witnessing substantial growth due to the increasing awareness of the health benefits of omega-3 fatty acids. EPA (Eicosapentaenoic Acid) and DHA (Docosahexaenoic Acid) are essential components for supporting cardiovascular and brain health. The market offers various product options, including fish oil, algal oil, and omega-3 supplements, making it convenient for consumers to incorporate these nutrients into their diets.

The rising adoption of omega-3-enriched functional foods is driving the EPA and DHA markets. Food manufacturers are incorporating EPA and DHA into a wide range of fortified food and beverages to cater to health-conscious consumers. For example, there has been an increase in the availability of omega-3-enriched milk, yogurt, and cereals. Moreover, the growing focus on pet health and nutrition has led to the inclusion of EPA and DHA in pet food products, driving the market's expansion in the pet nutrition segment.

Market Dynamics

Global Emphasis on Omega-3 Benefits and Healthcare Recommendations Propel EPA & DHA Market Growth

Health organizations and regulatory bodies worldwide have been emphasizing the importance of omega-3 fatty acids in promoting public health. Governments are implementing policies to encourage the consumption of EPA and DHA through dietary guidelines and public health campaigns. Additionally, regulations are in place to ensure the quality and safety of EPA and DHA products, providing consumers with the assurance of standardized and reliable supplements.

These supportive measures have contributed to increased consumer confidence, thereby boosting the EPA and DHA market trends. Furthermore, the inclusion of omega-3 supplementation in healthcare recommendations and treatment protocols has bolstered market growth. Healthcare professionals are increasingly recommending EPA and DHA supplements to patients with cardiovascular issues, inflammatory conditions, and other health concerns, further driving the demand for these essential fatty acids.

Rising Demand for Plant-Based Sources Propels EPA & DHA Market Growth

With the increasing awareness of sustainability and environmental concerns, there is a growing demand for plant-based sources of EPA and DHA, such as algal oil. Algae-derived omega-3 supplements have gained popularity among vegan and vegetarian consumers who seek an alternative to fish oil. Algal oil offers a sustainable and eco-friendly option, reducing the pressure on marine resources and mitigating the environmental impact of fishing.

As the plant-based movement gains momentum, the demand for EPA and DHA supplements sourced from algae is expected to rise, propelling the growth of the EPA and DHA markets. The market share of algal-based EPA and DHA products is projected to increase in response to changing consumer preferences and ethical considerations.

Contaminant Concerns Pose Challenges to EPA and DHA Market Growth

One of the key restraints of the EPA and DHA market is the potential risk of contaminants in fish oil and marine-based products. As these omega-3 fatty acids are commonly sourced from fish and other marine organisms, there is a possibility of environmental pollutants, heavy metals, and toxins accumulating in their bodies. Contaminants like mercury, PCBs, and dioxins can be present in certain fish species and marine oils, raising concerns among consumers about product safety and potential health risks.

To address this restraint, manufacturers and suppliers in the EPA and DHA market need to implement rigorous quality control measures, such as third-party testing and certifications, to ensure that their products meet safety standards and regulatory requirements. Offering purified and high-quality EPA and DHA supplements can help build consumer trust and overcome this restraint in the market.

COVID-19 Impact Analysis

The COVID-19 Analysis includes Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it to pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown, and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).

Segment Analysis

The global EPA & DHA market has been segmented by type, source, application, and region.

Dietary Supplements Dominate the EPA and DHA Market, Catering to Health-Conscious Consumers

The dietary supplements segment is holding the largest market share, around 45% of the EPA and DHA market. Dietary supplements containing EPA and DHA are widely consumed by individuals seeking to boost their omega-3 intake and improve overall health. These supplements offer a convenient and precise way to obtain the recommended daily dosage of these essential fatty acids.

Additionally, the rising awareness of the health benefits associated with EPA and DHA consumption has contributed to the growth of the dietary supplements segment. Moreover, EPA (Eicosapentaenoic Acid) and DHA (Docosahexaenoic Acid) are prominent types of omega-3 fatty acids found in marine oils, making them the key components of these dietary supplements. Marine oils, sourced from fish and algae, are rich in EPA and DHA, making them ideal for formulating high-quality supplements.

Geographical Analysis

Asia Pacific Emerges as a Growing Force in the EPA & DHA Market, Paving the Way for Expanding Market Share and Size

By region, the global EPA & DHA market is segmented into North America, South America, Europe, Asia-Pacific, Middle-east, and Africa.

The Asia-Pacific region's EPA and DHA market size is experiencing significant growth due to increasing consumer awareness of the health benefits associated with omega-3 fatty acids. Fish oil, algal oil, and omega-3 supplements have gained popularity as they are known to support cardiovascular health and brain function. The rising prevalence of chronic diseases has driven the demand for EPA and DHA products in this region.

As a result, companies are expanding their product offerings to cater to the diverse health needs of consumers. The EPA and DHA market share in the Asia-Pacific region is projected to witness substantial growth as more people embrace preventive healthcare measures. Additionally, the market size is expected to expand as consumers seek personalized and targeted solutions to address their specific health concerns.

Competitive Landscape

The major global players in the market include: Koninklijke DSM NV, Corbion N.V., BASF SE, The Archer Daniels Midland Company, Croda International Plc, KD Pharma Group, Lonza Group Ltd., Omega Protein Corporation, GC Rieber Oils AS, and Polaris.

Why Purchase the Report?

  • To visualize the global EPA & DHA market segmentation based on type, source, application, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities in the market by analyzing trends and co-development.
  • Excel data sheet with numerous data points of EPA & DHA market-level with all segments.
  • The PDF report consists of a cogently put-together market analysis after exhaustive qualitative interviews and an in-depth market study.
  • Product mapping is available as Excel consists of key products of all the major market players.

The global EPA & DHA market report would provide approximately 61 tables, 62 figures, and 190 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet, by Type
  • 3.2. Market Snippet, by Source
  • 3.3. Market Snippet, by Application
  • 3.4. Market Snippet, by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19 on the Market
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Eicosapentaenoic Acid (EPA)*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Docosahexaenoic Acid (DHA)

8. By Source

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 8.1.2. Market Attractiveness Index, By Source
  • 8.2. Algae Oil*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Krill oil
  • 8.4. Fish Oil
  • 8.5. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Infant Formulae*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Dietary Supplements
  • 9.4. Fortified Food and Beverages
  • 9.5. Pharmaceuticals
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America*
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. BASF SE
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Koninklijke DSM NV
  • 12.3. Corbion N.V.
  • 12.4. The Archer Daniels Midland Company
  • 12.5. Croda International Plc
  • 12.6. KD Pharma Group
  • 12.7. Lonza Group Ltd.
  • 12.8. Omega Protein Corporation
  • 12.9. GC Rieber Oils AS
  • 12.10. Polaris

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us